United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 799,500 | 798,600 | 794,400 | 735,900 | 748,900 |
| Cost of Goods | 100,900 | 87,600 | 92,500 | 75,900 | 83,100 |
| Gross Profit | 698,600 | 711,000 | 701,900 | 660,000 | 665,800 |
| Operating Expenses | 311,000 | 347,100 | 319,600 | 303,200 | 322,800 |
| Operating Income | 388,500 | 364,500 | 382,800 | 357,700 | 343,100 |
| Interest Expense | 3,000 | 7,300 | 6,100 | 7,900 | 10,100 |
| Other Income | 52,500 | 51,200 | 46,800 | 46,700 | 55,600 |
| Pre-tax Income | 438,000 | 408,400 | 423,500 | 396,500 | 388,600 |
| Income Tax | 99,300 | 98,900 | 101,300 | 95,200 | 79,500 |
| Net Income Continuous | 338,700 | 309,500 | 322,200 | 301,300 | 309,100 |
| Net Income | $338,700 | $309,500 | $322,200 | $301,300 | $309,100 |
| EPS Basic Total Ops | 7.73 | 6.86 | 7.18 | 6.73 | 6.93 |
| EPS Basic Continuous Ops | 7.73 | 6.86 | 7.18 | 6.72 | 6.93 |
| EPS Diluted Total Ops | 7.16 | 6.41 | 6.63 | 6.23 | 6.39 |
| EPS Diluted Continuous Ops | 7.16 | 6.41 | 6.63 | 6.23 | 6.39 |
| EPS Diluted Before Non-Recurring Items | 7.16 | 6.41 | 6.63 | 6.19 | 6.39 |
| EBITDA(a) | $410,400 | $385,600 | $402,600 | $377,400 | $362,200 |